Co-expression of steroid hormone receptors (estrogen receptor alpha and/or progesterone receptors) and Her2/neu (c-erbB-2) in breast cancer: clinical outcome following tamoxifen-based adjuvant therapy.

Gago, Francisco E; Fanelli, Mariel A; Ciocca, Daniel R

Gago, Francisco E; Fanelli, Mariel A; Ciocca, Daniel R.

Affiliation

Gago FE; Gynecology Department, Medical School, National University of Cuyo, Parque Gral, San Martín, 5500 Mendoza, Argentina.

J Steroid Biochem Mol Biol ; 98(1): 36-40, 2006 Jan.

Article in En | MEDLINE | ID: mdl-16188438

Subject(s)

Antineoplastic Agents, Hormonal/therapeutic use; Breast Neoplasms/drug therapy; Breast Neoplasms/metabolism; Estrogen Receptor alpha/metabolism; Receptor, ErbB-2/metabolism; Receptors, Progesterone/metabolism; Tamoxifen/therapeutic use; Adult; Aged; Aged, 80 and over; Breast Neoplasms/pathology; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Prospective Studies; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Tamoxifen / Breast Neoplasms / Receptors, Progesterone / Receptor, ErbB-2 / Antineoplastic Agents, Hormonal / Estrogen Receptor alpha Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Year: 2006 Type: Article

Search on Google

XML

PubMed Links